Navidea Biopharmaceuticals First Quarter 2012 Earnings and Business Update Conference Call Invitation

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB), specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the first quarter of 2012 on Wednesday, May 2, 2012 after market close. The announcement will be followed by a conference call with the investment community the following day, Thursday, May 3, 2012 at 8:30 am EDT.

Back to news